Aim: As the population ages, epilepsy among elderly people is increasing. Epileptic seizures in the elderly are mostly complex partial seizures without convulsions, so more caution is needed in the diagnosis of epilepsy. If epileptic seizures in the context of memory impairment are overlooked, epilepsy may be misdiagnosed as dementia. However, in older patients with epilepsy, there is a possibility that cognitive function may be impaired in the interictal phase. This study aims to investigate the efficacy of anti-epileptic drug (AED) treatment for patients with cognitive impairment and interictal epileptiform discharge (IED) on electroencephalography. Methods: The outcome of AED administration in 50 patients who exhibited IED was retrospectively investigated. Their cognitive functions were assessed by the Mini-Mental State Examination (MMSE) at both baseline and after AED administration. Results: In all patients who underwent electroencephalography, IED were temporal spikes, and re-examination of the 50 patients revealed that the frequency of temporal spikes had decreased or else disappeared in 41 patients (82%) after AED administration. In these 41 patients, the mean MMSE score significantly increased from 23.4 AE 3.7 at baseline to 24.7 AE 4.8 after AED treatment (P <0.01). Similarly, the mean serial 7s score (MMSE subscale) also improved significantly from 2.5 AE 1.8 to 3.6 AE 1.6 (P <0.01). The MMSE score was significantly improved only in the 41 patients with recovery of IED. Conclusion: AED treatment for elderly amnestic patients with temporal spikes was effective in improving cognitive decline and related electroencephalographic abnormalities. A more thorough search of IED is necessary in elderly amnesic patients because there is a possibility that IED modifies cognitive function.
INTRODUCTION
The proportion of elderly people in the population is expanding in advanced nations, and while the number of patients with dementia is increasing, epilepsy is also becoming more common. Among individuals over the age of 65, the prevalence of epilepsy has been reported to be more than twice as high as in younger generations. [1] [2] [3] Japanese society is ageing, and specialized memory clinics have been established to diagnose and treat patients with dementia. In most of these clinics, brain imaging using magnetic resonance imaging (MRI) or X-ray computed tomography is standard, but brain functional examination, especially by electroencephalography (EEG), is not considered to be routine. However, epilepsy, like dementia, is a disease common to the elderly. In the circumstances, amnesia due to epilepsy can easily be misdiagnosed as dementia; accordingly, more attention should be paid to memory clinic patients with subtle epilepsy.
There have been previous case reports of amnestic patients with interictal epileptiform discharges (IED) who have recovered their cognitive functions as a result of anti-epileptic drug (AED) treatment. 4, 5 However, conflicting reports have suggested that AED are not effective for such patients. 6 There have been few systematic investigations in this field. Liedorp et al. reported IED in 42 of 1674 (2.5%) memory clinic patients 6 ; among them, 60% had exhibited no clinical seizures. The prevalence of IED in our memory clinic was investigated, and it was found that 43 of 858 patients (5.0%) had IED, which appeared as temporal spikes on EEG. 7 Temporal spikes that predict the onset of partial seizure in the temporal lobe are commonplace IED in the elderly. At our memory clinic, amnestic patients with temporal spikes and without a history of epilepsy were generally diagnosed with mild cognitive impairment or Alzheimer's disease (AD). In these patients, convulsive seizures were rare, and even non-convulsive seizures were not always confirmed, but consciousness impairment existed. In addition, the cognitive dysfunction that prompted the visit to a memory clinic was recognized in all cases. If this cognitive dysfunction is related to epilepsy, it should be considered at the time of dementia diagnosis. However, it is unknown whether the IED affect cognitive function in elderly people. Can cognitive dysfunction with IED be treated by AED? It is noteworthy that the cognitive function of patients with IED might be improved with AED.
We conducted a retrospective study according to usual clinical practice, and herein we report how AED administration affected the cognitive impairment of elderly patients with IED. This is the first systematic study to report the efficacy of AED for cognitive decline during the interictal phase in aged amnestic patients.
METHODS

Patients and procedure
The subjects of this study were recruited from a memory clinic run by the Yokohama Comprehensive Care Continuum, where all patients are examined for cognitive function. Brain MRI (MAGNETOM Symphony syngo MR 1.5 T; Siemens Healthcare, Tokyo, Japan) and conventional EEG (Neurofax EEG-1524; Nihon Kohden Corporation, Tokyo, Japan) are routinely performed on the first visit. All data were retrospectively analyzed from medical records collected during routine clinical practice.
For the present study, amnestic patients with IED, almost all of whom exhibited temporal spikes, were recruited continuously from 2010 to 2015. The age of these patients ranged from 59 to 86 years (mean AE SD: 76.0 AE 5.7 years), and the male-to-female ratio was 16:34. All 50 patients had subjective or objective amnesia and visited the memory clinic. Even if obvious consciousness loss could not be confirmed in their medical history, minor consciousness impairment was recognized in most cases. Based on the results of EEG, patients may have developed a complex partial seizure (CPS).
AED were administered to treat CPS or latent CPS in these patients. A retrospective study was conducted on 50 patients who agreed to be evaluated for cognitive function after AED treatment.
Based on examination using a 1.5-T MRI, no patients had hippocampal sclerosis among these 50 cases. However, the detection sensitivity of a 1.5-T MRI is limited with regard to hippocampal sclerosis. Brain morphology in the atrophied hippocampal region was evaluated by the voxel-based specific regional analysis system for AD (VSRAD), a volume analysis of images obtained from MRI scans. The Z-scores obtained by VSRAD indicate the degree of grey matter atrophy in the hippocampal entorhinal cortex in the diagnosis of AD, and a Z-score ≥2.0 indicates considerable atrophy in this region. 8, 9 In this study, patients with a Z-score ≥2.0
were excluded to avoid the effects of severe hippocampal atrophy, which is strongly associated with hippocampal sclerosis or dementia. EEG was recorded for 30 min with the subjects in a resting state with their eyes closed. EEG was recorded at 19 sites on the scalp arranged according to the international 10-20 system (Fp1, Fp2, F3, F4, F7, F8, Fz, T3, T4, T5, T6, C3, C4, Cz, P3, P4, Pz), with a reference electrode on the earlobes (left or right). The digital EEG was recorded at a sampling rate of 500 Hz, 120 Hz high frequency filter setting, time constant 0.3 s, and impedance rate 10 KΩ.
Neuropsychological tests and a method of treatment with AED Cognitive function was evaluated by the Mini-Mental State Examination (MMSE) both at baseline and several months later, once plasma AED concentration had reached an effective level. EEG was also reexamined after confirmation of adequate plasma AED levels.
In accordance with standard procedure for partial seizures, carbamazepine (CBZ) was used as a firstline treatment. If skin eruptions or liver dysfunction occurred, CBZ was discontinued and replaced by another AED or, in cases of insufficient efficacy, augmented with another AED.
Statistical analysis
A paired t-test was used to examine differences in MMSE score before and after AED administration. Student's t-test and χ 2 test were used to examine differences in case demographics. All statistical analysis was performed using PASW Statistics 18 (SPSS Japan, Tokyo, Japan).
Ethical practice
This study was approved by the Ethics Committee of Yokohama Comprehensive Care Continuum, and all patients gave written informed consent.
RESULTS
Subjects and AED used for treatments All subjects were examined by brain imaging using MRI, and none of them was found to have marked cerebrovascular disease or severe hippocampal atrophy, as judged by the VSRAD Z-scores. The epileptiform discharge of the 50 patients was observed as spikes distributed across the temporal area, primarily in the anterior temporal lobes. The temporal spikes appeared in the left hemisphere in 8 cases, the right hemisphere in 5 cases, and bilaterally in 37 cases.
Of the 50 cases, 41 were treated by CBZ monotherapy (100-500 mg/day; mean: 196.34 AE 86.16 mg/day), 2 by clonazepam (CZP) monotherapy (0.5-2.0 mg/day; mean 1.25 mg/day), 2 by levetiracetam monotherapy (250 mg/day), 2 by valproate monotherapy (300-400 mg/day; mean: 350 mg/day), and 1 by lamotrigine monotherapy (75 mg/day).
Additionally, two were treated by combination therapy with two AED (valproate and lamotrigine, or CZP and levetiracetam). AED effectively treated CPS and improved consciousness impairment.
MMSE scores after AED treatment and after an interval of 3~45 months (mean: 11.4 AE 8.4) were compared with baseline, and the changes were examined by a paired t-test. There was a difference in the period during which MMSE was re-evaluated after AED administration. This is because there was a difference in compliance between subjects, and also some subjects were patients with transient epileptic amnesia who maintained cognitive function for a long time.
Change in the MMSE score and subscales after AED treatment The mean MMSE score before AED administration was 23.56 AE 3.72, and this increased to 24.52 AE 4.91 after medication was administered. The MMSE scores after AED administration were not significantly different from the baseline MMSE scores.
The changes in MMSE subscale responsiveness to AED are presented in Table 1 . The scores for serial 7s and delayed recall of three named objects were improved by AED administration. The mean score for serial 7s increased from 2.76 AE 1.85 at baseline to 3.64 AE 1.59 after AED administration. The difference in serial 7s scores before and after AED treatment was significant (P < 0.01).
Of the 50 cases, 23 (46%) had an increased serial 7s score, 17 (34%) had an unchanged score, and 10 (20%) had a decreased score. (Table 2) The serial 7s score of the group without the unchanged scores was relatively high (mean AE SD: 4.29 AE 1.34). We could not find significant differences in cognitive function between each administrated AED: CBZ, valproate, levetiracetam, CZP, and lamotrigine. The effects of nootropics, such as cholinesterase inhibitor and memantine, administered in conjunction with AED were also evaluated. Changes in the serial 7s score in 17 cases with nootropics combined with AED are shown in Table 3 . There was no significant difference in the number of cases in which nootropics and AED were administered among the three serial 7s score groups (increased, unchanged, and decreased) according to the χ 2 test (P = 0.08). Therefore, serial 7s improvement was apparently unrelated to nootropic administration, and it can be concluded that the recovery of cognitive function was due to the AED treatment alone.
Change in EEG findings after AED treatment
The IED present in all 50 cases were observed as spikes in the temporal area, and these abnormalities were effectively managed by AED administration. EEG was re-examined after AED treatment in all cases. The observed IED are exemplified by Figure 1 . The temporal spikes disappeared in 31 cases (62%) and decreased in frequency in 10 cases (20%), but it was unchanged in 9 cases (18%). As such, the spikes were effectively treated by AED in 41 cases (82%). The frequency of spikes before and after administration of AED was graded as None, I, II, III, and IV (Table 4) . To investigate the relationship between AED plasma level and the change in IED, the 41 cases treated with CBZ monotherapy were examined. IED disappeared in 23 cases, decreased in 10 cases, and were unchanged in 8 cases. There was no significant difference in the mean AE SD plasma concentration of CBZ among the disappeared group (5.17 AE 1.37 μg/mL), the decreased group (4.66 AE 1.57 μg/mL), and the unchanged group (5.84 AE 1.33 μg/mL).
In the nine cases with unchanged temporal spikes, the plasma AED concentrations were maintained within the effective range. Among these patients, eight were treated with CBZ (100-300 mg/day; plasmatic level: 4.0-7.5 μg/mL) and one was treated with CZP (2.0 mg/day; plasmatic level: 29 ng/mL).
There were no significant differences in age, years of education, Z-score of VSRAD, or month of AED treatment by Student's t-test. Likewise, there were no differences in sex and Clinical Dementia Rating score by χ 2 test between the two groups with (n = 41) or without (n = 9) successful treatment for IED. (Tables 5-6 ).
Relationship between the changes in MMSE score and the improvements in IED after AED treatment The effect of changes in IED frequency on cognitive function was investigated. The subjects were divided into two groups according to how their IED responded after AED treatment: (i) improved group with response on EEG (IED disappeared and decreased frequency); or (iii) unimproved group without response on EEG (IED unchanged) ( Table 7 ). In the improved group, serial 7s significantly increased from 2.49 AE 1.83 at baseline to 3.61 AE 1.61 (P < 0.01) after AED, and total MMSE significantly increased from 23.37 AE 3.66 at baseline to 24.71 AE 4.79 (P < 0.01). In the unimproved group, there were no significant differences in MMSE and subscale scores before and after AED administration. However, the serial 7s score of the unimproved group Anti-epileptic drugs improved attention © 2018 Japanese Psychogeriatric Society (4.00 AE 1.41) was significantly higher than that of the improved group (2.49 AE 1.83) at baseline (P < 0.05). In the unimproved group (n = 9), serial 7s scores were unchanged in six cases (67%), decreased in two cases (22%), and increased in one case (11%).
DISCUSSION
AED administration was effective for the treatment of CPS. AED treatment results were also evaluated in terms of cognitive function. The serial 7s score of the MMSE was significantly increased or unchanged in 80% of patients after AED treatment, but it did decrease in 20% of patients. Changes in cognitive function after AED administration were compared between the improved and unimproved groups. The total MMSE and serial 7s were significantly increased only in the improved group.
The serial 7s task requires functioning attention and calculations. We speculated that AED administration may improve cognitive function by antagonizing IED.
There have been some reports that IED interfere with memory function. Kleen et al. reported that hippocampal IED may disrupt memory maintenance and retrieval based on a study of 10 adult patients using depth electrodes implanted into the hippocampus. 10 IED are not uncommon in patients with complaints of memory impairment. In our previous study, 7 temporal spikes as IED were present in 5% of memory clinic patients, whereas Liedorp et al. reported a rate of only 2.5%. 6 This difference in prevalence may be attributable to the testing conditions. Epileptiform discharge commonly appears during shallow sleep. Our EEG examination was carried out under conditions in which subjects fell asleep naturally, whereas in the study by Liedorp et al., the EEG examinations were performed under conditions in which the subjects did not sleep.
In this study, all subjects with temporal spikes possibly had CPS, including subtle seizures. The occurrence of temporal spikes is usually the preparation status of the CPS in the ictal phase. However, long-term EEG or video monitoring could not be performed, so it is uncertain whether the patients developed CPS.
The temporal spikes observed in all our subjects were accompanied with cognitive decline. A spike is an abnormal indication of hyper-excited or hypersynchronized neuronal activity. Temporal spikes possibly induced functional failure in the medial temporal lobe, leading to cognitive decline. Epilepsy with transient and recurrent memory impairment was described as transient epileptic amnesia (TEA) by Kapur. 11 Patient symptoms in this study, such as memory impairment without convulsions, resembled those characteristic of TEA. The memory functions most affected by TEA are remote and autobiographical memory, rather than recent memory. 12, 13 At least 6 of our 50 patients who retained high cognitive function for several years were eventually diagnosed as having TEA without dementia such as AD. However, many of patients in this study had sustainable cognitive decline similar to AD during interictal phases. Imfeld et al. reported that the relative risk of developing seizures or epilepsy in association with AD was 6.6 times higher than in patients without dementia. 14 Vossel et al. reported that AD with subclinical epileptiform activity was associated with early onset of cognitive decline. 15 They also stressed that ADrelated neural network hyper-synchronization is an early and potentially treatable component of the disease. Several reports of laboratory experiments have indicated that the overexpression of amyloid-β (Aβ) protein causes epileptiform discharges and seizures in transgenic animals. 16, 17 This means that Aβ protein can also cause seizures in the brain of AD patients. Lam et al. reported that clinically silent hippocampal seizures and epileptiform spikes were detected using intracranial electrodes in the mesial temporal of AD patients. 18 Although Aβ pathology in our patients was uncertain, Aβ may play a role in memory impairment with subclinical seizure. In this study, some of our patients possibly had Aβ pathology in combination with seizure. Also, because all of our cases of epilepsy could not be diagnosed as TEA, some could be considered as cases of partial seizure with possible coexistence of AD pathology. Vossel et al. reported that subclinical epileptiform activity was detected in 42.4% of AD patients, and AD patients with subclinical epileptiform discharge had faster declines in global cognition and executive function. 19 Therefore, IED associated with AD seems worth treating. After AED treatment, IED was improved in 82% of patients on EEG. In 18% of patients, IED did not change, but according to plasma concentration evaluation, the dose of AED was sufficient. Moreover, no significant differences in plasma CBZ concentration were observed between the improved and unimproved groups. Almost all patients in each group displayed an effective concentration of plasma AED (CBZ) level, but some patients still presented a similar epileptiform discharge. Even if a sufficient amount of conventional AED is used, hyperactivity of nerve cells may not be suppressed. Accordingly, research related to new, more tolerable AED is required to determine the best course of treatment for cognitive decline by subclinical seizure.
In the present study, it should be noted that subjects who were not treated with AED treatment were not included as control, which may limit the validity of the findings. Also, a mean annual deterioration in MMSE score of 3.3-3.4 has been reported among AD patients, 20, 21 but in this study, the mean MMSE score of patients improved from 23.6 to 24.5 after about 11 months of AED treatment.
Proactive detection of IED in amnestic patients should make it possible to find a potential CPS and related cognitive decline. It encourages the active AED treatment for IED-related cognitive dysfunction.
